Dr. Dev G. Mehta, DO

Dr. Mehta practices at Newyork-Presbyterian Medical Group/Queens in Forest Hills, New York.

Dr. Mehta's NPI, 1942688288, was assigned on May 6, 2015. Dr. Mehta graduated from Arizona College of Osteopathic Medicine - Glendale in 2015. Dr. Mehta holds New York license 311301.

Dr. Mehta's primary practice is Newyork-Presbyterian Medical Group/Queens, at 112-5 Queens Blvd, Forest Hills, NY 11375 in Queens County. The practice phone is (718) 670-1019.

Dr. Mehta's primary practice is Newyork-Presbyterian Medical Group/Queens in Forest Hills, New York. Dr. Mehta is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Dr. Mehta to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mehta is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Mehta is licensed in New York.

Dmand AI lists alzheimer's disease, fibromyalgia and chronic pain, lower back pain, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain, neuropathy, parkinson's disease and sleep apnea among the conditions Dr. Mehta treats.

CMS data shows 513 Medicare services from Dr. Mehta across 8 procedure codes in 2024, for 255 Medicare patients. Medicare paid $43,931 for them.

CMS counts 255 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 65, with 65% women.

In 2024, Dr. Mehta wrote 1,112 Medicare Part D claims for 205 patients. 77% of them were for generic drugs. CMS names the drug for 893 of them, across 26 drugs with 11 or more claims each, at $306,886 in total drug cost. In 2023, CMS named 464 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mehta for performance year 2024, reported through an alternative payment model (APM). Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Dmand AI links 12 papers to Dr. Mehta, published from 2013 to 2021. 2020 was the busiest year, with 4. The most frequent topics are Magnetic Resonance Imaging. Dr. Mehta has published most often in Headache. Dr. Mehta's most frequent co-authors are Hussam A. Yacoub, DO, Deborah L. Renaud, MD and Jerry William Swanson, MD.

CMS Open Payments shows 49 general payments to Dr. Mehta from 21 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $1,735.

Dr. Mehta graduated from Arizona College of Osteopathic Medicine - Glendale in 2015. Dr. Mehta is a member of AAN.

Dr. Mehta is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.